Companies › OLMA

OLEMA PHARMACEUTICALS INC (OLMA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001750284 · EDGAR filings · Updated 2026-07-27

OLEMA PHARMACEUTICALS INC (OLMA) has reported institutional ownership of 116.4%, with 196 institutional managers holding positions valued at $1.51B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (3)

• 2026-07-27 — Insider transaction reported (Form 4)
• 2026-07-24 — Notice of proposed sale filed (Form 144)
• 2026-07-23 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-23 — Insider transaction reported (Form 4)
• 2026-06-23 — Insider transaction reported (Form 4)
• 2026-06-23 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, OLEMA PHARMACEUTICALS INC has 196 institutional holders and institutional ownership of 116.4%.

Insider activity

Insiders reported 46 transactions (0 buys, 27 sells) across 11 reporting insiders, with a net reported value of −$24.7M.

Data flags from SEC filings

Related companies

MAZE THERAPEUTICS INC (MAZE) · ENOVIS CORPORATION COM (ENOV) · ESTABLISHMENT LABS HLDGS INC (ESTA) · PACS GROUP (PACS) · ORIC PHARMACEUTICALS INC (ORIC) · TANDEM DIABETES CARE INC COM NEW (TNDM)